XML 74 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders' equity
9 Months Ended
Sep. 30, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' equity STOCKHOLDERS’ EQUITY
Common equity transactions

Pursuant to our outstanding forward equity sales agreements, we have the ability to issue an aggregate of 699 thousand shares of common stock and to receive net proceeds of approximately $103.1 million. During the nine months ended September 30, 2023, we did not issue any new equity under our ATM program, including any shares to settle our forward equity agreements outstanding as of December 31, 2022. In addition, the remaining amount available under our ATM program for future sales of common stock aggregated $141.9 million as of September 30, 2023.

Dividends

During the three months ended September 30, 2023, we declared cash dividends on our common stock aggregating $214.5 million, or $1.24 per share. In October 2023, we paid the cash dividends on our common stock declared for the three months ended September 30, 2023.

During the three months ended June 30, 2023, we declared cash dividends on our common stock aggregating $214.6 million, or $1.24 per share. In July 2023, we paid the cash dividends on our common stock declared for the three months ended June 30, 2023.

During the three months ended March 31, 2023, we declared cash dividends on our common stock aggregating $209.3 million, or $1.21 per share. In April 2023, we paid the cash dividends on our common stock declared for the three months ended March 31, 2023.

Accumulated other comprehensive loss

The change in accumulated other comprehensive loss attributable to Alexandria Real Estate Equities, Inc.’s stockholders during the nine months ended September 30, 2023 was primarily due to net unrealized losses of $4.2 million on foreign currency translation related to our operations in Canada.

Common stock, preferred stock, and excess stock authorizations

Our charter authorizes the issuance of 400.0 million shares of common stock, of which 171.0 million shares were issued and outstanding as of September 30, 2023. Our charter also authorizes the issuance of up to 100.0 million shares of preferred stock, none of which were issued and outstanding as of September 30, 2023. In addition, 200.0 million shares of “excess stock” (as defined in our charter) are authorized, none of which were issued and outstanding as of September 30, 2023.